Bloomberg |
A Drug Made from Cannabis Moves Closer to Approval in a US First
Bloomberg U.S. drug regulators are edging closer to approving the first-ever medicine derived from a marijuana plant, an experimental epilepsy treatment developed by GW Pharmaceuticals Plc. On Thursday, a panel of outside advisers to the Food and Drug ... US experts back marijuana-based drug for childhood seizures Marijuana-based Drug Gets Positive Review From US Agency FDA panel unanimously backs GW Pharma's cannabis-based epilepsy drug |
from Health - Google News https://ift.tt/2HAhDnW
EmoticonEmoticon